60 Degrees Pharmaceuticals I
13F holders, Q4 2024 (December 31)8holders +1
4new positions
3sold out
$1.29avg. 13F price*
At the end of Q4 2024, 8 institutions reported holding 60 Degrees Pharmaceuticals I in their 13F filings, up 1 from Q3 2024. 4 opened new positions and 3 sold out. The largest holders were Armistice Capital, LLC ($128K), UBS Group AG ($26K) and Two Sigma Securities, LLC ($20K).
- Company
- 60 Degrees Pharmaceuticals I
- CUSIP
- 83006G203
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $164K |
| Exits | 3 | $34K |
All 13F filers, Q3 2024 → Q4 2024: 146,830 shares bought and 26,773 shares sold, net +120,057 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Armistice Capital, LLC | 0.00% | New | 98,934 | $128K |
| UBS Group AG | 0.00% | Add +516.4% | 20,408 | $26K |
| Two Sigma Securities, LLC | 0.00% | New | 15,444 | $20K |
| HRT Financial LP | 0.00% | New | 12,591 | $16K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +153.2% | 3,730 | $5K |
| Safe Harbor Fiduciary, LLC | 0.00% | No change | 1,375 | $2K |
| Osaic Holdings, Inc. | 0.00% | New | 500 | $645 |
| Bank of America Corp. | 0.00% | Add +116.7% | 13 | $17 |
"% of holder's portfolio" is 60 DEGREES PHARMACEUTICALS I's weight in each manager's 13F, not the share of 60 Degrees Pharmaceuticals I the manager owns.